home / stock / xyno / xyno short
Short Information | Xynomic Pharmaceuticals Holdings Inc (OTCMKTS:XYNO)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 53,859 |
Total Actual Volume | 122,316 |
Short Trends | |
---|---|
Cover Days | 4 |
Short Days | 14 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 2,693 |
Average Short Percentage | 65.96% |
Is there a XYNO Short Squeeze or Breakout about to happen?
See the XYNO Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-12-2021 | $2.22 | $2.22 | $2.22 | $2.22 | 132 | 132 | 100% |
04-14-2021 | $2.16 | $2.16 | $2.16 | $2.16 | 131 | 131 | 100% |
03-22-2021 | $2.08 | $2.08 | $2.08 | $2.08 | 1,000 | 1,000 | 100% |
02-23-2021 | $2.5 | $2.5 | $2.5 | $2.5 | 320 | 320 | 100% |
02-17-2021 | $2.1 | $2.5 | $2.5 | $2.1 | 1,580 | 579 | 36.65% |
02-05-2021 | $2 | $2.85 | $2.85 | $2 | 3,123 | 200 | 6.4% |
02-04-2021 | $3.5 | $2 | $3.5 | $2 | 506 | 306 | 60.47% |
01-29-2021 | $3.79 | $3.77 | $3.79 | $3.77 | 732 | 500 | 68.31% |
01-08-2021 | $2.21 | $2.41 | $2.41 | $2.21 | 460 | 230 | 50% |
12-31-2020 | $2.85 | $2.01 | $2.85 | $1.74 | 4,600 | 500 | 10.87% |
12-30-2020 | $3.84 | $3.84 | $3.84 | $3.84 | 230 | 30 | 13.04% |
12-29-2020 | $3.1 | $3.84 | $3.84 | $3.1 | 8,970 | 5,970 | 66.56% |
12-23-2020 | $2.62 | $2.62 | $2.62 | $2.62 | 100 | 100 | 100% |
11-30-2020 | $2.6 | $2.6 | $2.6 | $2.6 | 237 | 227 | 95.78% |
11-17-2020 | $2.6 | $2.6 | $2.6 | $2.6 | 129 | 129 | 100% |
11-16-2020 | $2.6 | $2.6 | $2.6 | $2.6 | 531 | 31 | 5.84% |
11-12-2020 | $2.55 | $2.55 | $2.55 | $2.55 | 160 | 100 | 62.5% |
10-23-2020 | $2.0825 | $2.0825 | $2.0825 | $2.0825 | 200 | 200 | 100% |
10-22-2020 | $1.43 | $1.43 | $1.43 | $1.43 | 151 | 150 | 99.34% |
10-21-2020 | $2.09 | $1.29 | $2.09 | $1.29 | 99,024 | 43,024 | 43.45% |
News, Short Squeeze, Breakout and More Instantly...
Xynomic Pharmaceuticals Holdings Inc Company Name:
XYNO Stock Symbol:
OTCMKTS Market:
SHANGHAI, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Xynomic Pharmaceuticals Holdings, Inc. (“Xynomic”, stock ticker: XYNO), a clinical stage US-China oncology drug development company, today announced that the U.S. Food and Drug Administration (“FDA”) has granted Fast-T...
SHANGHAI, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Xynomic Pharmaceuticals Holdings, Inc. (“Xynomic”, stock ticker: XYNO), a clinical stage US-China oncology drug development company, today announced the dosing of the first Chinese patient in its on-going global pivotal Phase ...
RALEIGH, N.C. and SHANGHAI, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Xynomic Pharmaceuticals Holdings, Inc. (“Xynomic”, stock ticker: XYNO), a clinical stage US-China oncology drug development company, announced encouraging interim data from an ongoing Phase 1b study of its lead cand...